Tolfenamic acid attenuated learning and memory deficits in AD transgenic mice through inhibiting the expression of APP, BACE1, and SP1-mediated CDK5/hyperphosphorylated tau [11, 12]. Here, CDK5 is linked to Alzheimer disease.